1 - 10 out of 13,555Page size: 10

  1. Households or hotspots? Defining intervention targets for malaria elimination in Ratanakiri Province, eastern Cambodia. / Bannister-Tyrrell, Melanie; Krit, Meryam; Sluydts, Vincent; Tho, Sochantha; Sokny, Mao; Mean, Vanna; Kim, Saorin; Menard, Didier; Grietens, Koen Peeters; Abrams, Steven; Hens, Niel; Coosemans, Marc; Bassat, Quique; van Hensbroek, Michael Boele; Durnez, Lies; Van Bortel, Wim.

    In: Journal of Infectious Diseases, 26.04.2019.

    Research output: Contribution to journal › Article › Research › peer-review

  2. Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania : a retrospective cohort study. / Mollel, Edson; Lekule, Isack; Lynen, Lutgarde; Decroo, Tom.

    In: International Health, 26.02.2019.

    Research output: Contribution to journal › Article › Research › peer-review

  3. Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient. / Abongomera, Charles; Battaglioli, Tullia; Adera, Cherinet; Ritmeijer, Koert.

    In: International Journal of Infectious Diseases, 18.02.2019.

    Research output: Contribution to journal › Article › Research › peer-review

  4. Integration of Human African Trypanosomiasis Control Activities into Primary Health Services in the Democratic Republic of the Congo : A Qualitative Study of Stakeholder Perceptions. / Mulenga, Philippe; Boelaert, Marleen; Lutumba, Pascal; Vander Kelen, Catiane; Coppieters, Yves; Chenge, Faustin; Lumbala, Crispin; Luboya, Oscar; Mpanya, Alain.

    In: American Journal of Tropical Medicine and Hygiene, 04.02.2019.

    Research output: Contribution to journal › A1: Web of Science-article › Research › peer-review

  5. Challenges in diagnosing Zika-experiences from a reference laboratory n a non-endemic setting. / Van den Bossche, Dorien; Michiels, Johan; Cnops, Lieselotte; Foque, Nikki; Meersman, Kathleen; Huits, Ralph; Ariën, Kevin K; Van Esbroeck, Marjan.

    In: European Journal of Clinical Microbiology and Infectious Diseases, 24.01.2019.

    Research output: Contribution to journal › A1: Web of Science-article › Research › peer-review

  6. Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2) : an open-label, multicentre, single-arm, phase 3b trial. / Boerekamps, Anne; De Weggheleire, Anja; van den Berk, Guido E; Lauw, Fanny N; Claassen, Mark A A; Posthouwer, Dirk; Bierman, Wouter F; Hullegie, Sebastiaan J; Popping, Stephanie; van de Vijver, David A C M; Dofferhoff, Anthonius S M; Kootstra, Gert Jan; Leyten, Eliane M; den Hollander, Jan; van Kasteren, Marjo E; Soetekouw, Robert; Ammerlaan, Heidi S M; Schinkel, Janke; Florence, Eric; Arends, Joop E; Rijnders, Bart J A.

    In: The Lancet Gastroenterology & Hepatology, 16.01.2019.

    Research output: Contribution to journal › Article › Research › peer-review

  7. Rationale and design of the SI! Program for health promotion in elementary students aged 6 to 11 years: A cluster randomized trial. / Santos-Beneit, Gloria; Bodega, Patricia; de Miguel, Mercedes; Rodríguez, Carla; Carral, Vanesa; Orrit, Xavier; Haro, Domènech; Carvajal, Isabel; de Cos-Gandoy, Amaya; Peñalvo, José Luis; Gómez-Pardo, Emilia; Oliva, Belén; Ibañez, Borja; Fernández-Alvira, Juan Miguel; Fernández-Jiménez, Rodrigo; Fuster, Valentin.

    In: American Heart Journal, Vol. 210, 08.01.2019, p. 9-17.

    Research output: Contribution to journal › A1: Web of Science-article › Research › peer-review

  8. Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel. / ALERRT-WHO Workshop.

    In: BMC Medical Ethics, Vol. 20, No. 1, 29, 2019.

    Research output: Contribution to journal › A1: Web of Science-article › Research › peer-review

  9. Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe. / ADVANCE Consortium; P95; UNIBAS; EMA; ECDC; SURREY; EMC; SYNAPSE; OU; LSHTM; PEDIANET; KI; ASLCR; AEMPS; AUH; UTA; SCIENSANO; MHRA; SSI; RCGP; RIVM; GSK; SP; NOVARTIS; MSD; JANSSEN; PFIZER; TAKEDA; ARS Toscana; IDIAP JORDI GOL; ADVANCE; ESDY; HCDCP; IMB; AIFA; ANSM; VVKT; WUM; PHE; BCF; ICL; UOA; NCE; FISABIO; EOF; THL; UNIME; IRD; VGRID; UMCU.

    In: Vaccine, Vol. 37, No. 25, 2019, p. 3278-3289.

    Research output: Contribution to journal › A1: Web of Science-article › Research › peer-review

  10. iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy. / iHIVARNA Consortium.

    In: Trials, Vol. 20, 361, 2019.

    Research output: Contribution to journal › A1: Web of Science-article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...1356 Next